Opportunity
Federal Register #2026-11911
DEA Notice: Importer Registration Application for Controlled Substances by VHG Labs DBA LGC Standards
Buyer
Drug Enforcement Administration
Posted
June 15, 2026
Respond By
July 15, 2026
Identifier
2026-11911
This opportunity involves a notice from the Drug Enforcement Administration (DEA) regarding an application for importer registration: - Government Buyer: - Department of Justice (DOJ) - Drug Enforcement Administration (DEA) - Applicant/Vendor: - VHG Labs DBA LGC Standards - Products/Services Requested: - Registration to import a wide range of controlled substances - Substances include various fentanyl analogs (e.g., acetyl-alpha-methylfentanyl, beta-hydroxyfentanyl, thiofentanyl), methamphetamine, methylphenidate, amobarbital, pentobarbital, secobarbital, glutethimide, nabilone, phencyclidine, phenylacetone, dihydrocodeine, ecgonine, ethylmorphine, levomethorphan, levorphanol, meperidine, dextropropoxyphene (bulk), levo-alphacetylmethadol, noroxymorphone, racemethorphan, and others - Unique/Notable Requirements: - The notice is for registration as an importer, not for procurement of goods or services - Only VHG Labs DBA LGC Standards is mentioned as the applicant - The DEA invites comments and requests for hearings from registered bulk manufacturers and applicants regarding the proposed registration - No specific product quantities, part numbers, or OEMs (other than the applicant) are listed - No procurement or purchase is being solicited; this is a regulatory notice
Description
VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). The notice invites registered bulk manufacturers and applicants to submit electronic comments or objections to the issuance of the proposed registration. Interested parties may also file a written request for a hearing on the application. Comments and requests for hearings are due by July 15, 2026.